可孚医疗
(301087)
| 流通市值：87.08亿 | | | 总市值：93.65亿 |
| 流通股本：1.94亿 | | | 总股本：2.09亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,397,791,920.73 | 1,495,764,000.12 | 737,792,254.37 | 2,982,931,130.48 |
| 营业收入 | 2,397,791,920.73 | 1,495,764,000.12 | 737,792,254.37 | 2,982,931,130.48 |
| 二、营业总成本 | 2,140,937,840.58 | 1,324,393,499.85 | 646,327,861.69 | 2,630,658,146.25 |
| 营业成本 | 1,118,462,515.9 | 710,640,835.64 | 352,894,626.27 | 1,436,084,139.16 |
| 税金及附加 | 26,136,687.99 | 16,224,836.4 | 7,186,093.72 | 26,285,794.08 |
| 销售费用 | 815,836,447.67 | 480,220,301.66 | 228,420,929.02 | 973,313,475.19 |
| 管理费用 | 123,183,864.5 | 80,360,277.49 | 40,596,125.82 | 121,393,005.12 |
| 研发费用 | 61,091,966.84 | 40,048,843.36 | 18,836,066.75 | 96,409,820.72 |
| 财务费用 | -3,773,642.32 | -3,101,594.7 | -1,605,979.89 | -22,828,088.02 |
| 其中:利息费用 | 11,014,162.32 | 7,310,504.62 | 2,867,033.16 | 17,912,039.08 |
| 其中:利息收入 | 18,284,724.08 | 12,203,188.06 | 5,903,846.9 | 42,368,248.72 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 13,885,783.64 | 10,980,459.26 | 7,290,001.24 | 9,399,977.79 |
| 加:投资收益 | 18,180,571.98 | 14,394,019.38 | 10,327,107.82 | 12,341,782.68 |
| 资产处置收益 | -695,656.48 | -579,008.36 | 87,558.44 | 5,879,979.53 |
| 资产减值损失(新) | -27,752,399.95 | -30,929,823.65 | -24,570,225.42 | -33,802,744.49 |
| 信用减值损失(新) | -1,146,418.95 | -1,191,912.74 | -2,210,612.65 | -4,950,220.66 |
| 其他收益 | 42,484,969.26 | 33,031,881.09 | 27,279,599.78 | 32,162,339.36 |
| 四、营业利润 | 301,810,929.65 | 197,076,115.25 | 109,667,821.89 | 373,304,098.44 |
| 加:营业外收入 | 5,897,448.15 | 4,762,455.6 | 799,959.72 | 6,278,453.4 |
| 减:营业外支出 | 3,531,274.67 | 2,179,574.46 | 1,041,080.34 | 7,583,425.85 |
| 五、利润总额 | 304,177,103.13 | 199,658,996.39 | 109,426,701.27 | 371,999,125.99 |
| 减:所得税费用 | 44,669,457.4 | 33,016,084.79 | 17,853,842.11 | 59,655,572.38 |
| 六、净利润 | 259,507,645.73 | 166,642,911.6 | 91,572,859.16 | 312,343,553.61 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 259,507,645.73 | 166,642,911.6 | 91,572,859.16 | 312,343,553.61 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 260,217,303.07 | 167,387,519.03 | 91,425,130.39 | 311,750,944.39 |
| 少数股东损益 | -709,657.34 | -744,607.43 | 147,728.77 | 592,609.22 |
| 扣除非经常损益后的净利润 | 221,991,674.51 | 136,189,004.84 | 68,522,530.19 | 275,062,929.19 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 1.28 | 0.82 | 0.45 | 1.53 |
| (二)稀释每股收益 | 1.27 | 0.81 | 0.45 | 1.51 |
| 八、其他综合收益 | 643,588.1 | - | - | - |
| 归属于母公司股东的其他综合收益 | 563,775.39 | - | - | - |
| 九、综合收益总额 | 260,151,233.83 | 166,642,911.6 | 91,572,859.16 | 312,343,553.61 |
| 归属于母公司股东的综合收益总额 | 260,781,078.46 | 167,387,519.03 | 91,425,130.39 | 311,750,944.39 |
| 归属于少数股东的综合收益总额 | -629,844.63 | -744,607.43 | 147,728.77 | 592,609.22 |
| 公告日期 | 2025-10-30 | 2025-08-26 | 2025-04-29 | 2025-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |